Literature DB >> 20368489

Headache and biomarkers predictive of vascular disease in a representative sample of US children.

Karin B Nelson1, Amanda Kalaydjian Richardson, Jianping He, Tarranum M Lateef, Suzan Khoromi, Kathleen R Merikangas.   

Abstract

OBJECTIVE: To examine the association of childhood headache disorders with markers of risk for cardiovascular and cerebrovascular disease.
DESIGN: Information was collected on severe or recurrent headache or migraine in childhood or adolescence and on biomarkers predictive of vascular disease.
SETTING: The National Health and Nutrition Survey, a nationally representative health survey. PARTICIPANTS: Children or adolescents aged 4 to 19 years (n = 11 770) who took part in the National Health and Nutrition Survey in 1999 through 2004. MAIN EXPOSURE: Headache. MAIN OUTCOME MEASURES: Body mass index; levels of C-reactive protein, homocysteine, serum and red blood cell folate, vitamin B(12), methylmalonic acid, total cholesterol, high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, triglycerides, and uric acid; and platelet count.
RESULTS: Mean values for body mass index, C-reactive protein, and homocysteine were higher in children with than without headaches, and more children with headaches were in the highest quintile of risk for these factors. Serum and red blood cell folate levels were lower in children with headache. More children with headache were in the highest quintile of risk for 3 or more of these factors.
CONCLUSIONS: Several important risk factors for long-term vascular morbidity cluster in children and adolescents with severe or recurrent headache or migraine. Further study and screening of children with headaches may permit improved preventive management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368489      PMCID: PMC2938784          DOI: 10.1001/archpediatrics.2010.17

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  41 in total

1.  A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes.

Authors:  Stylianos Kapiotis; Gregor Holzer; Georg Schaller; Markus Haumer; Harald Widhalm; Daniel Weghuber; Bernd Jilma; Georg Röggla; Michael Wolzt; Kurt Widhalm; Oswald F Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-14       Impact factor: 8.311

2.  Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.

Authors:  Robert J Glynn; Jean G MacFadyen; Paul M Ridker
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

3.  Metabolic and genetic risk factors for migraine in children.

Authors:  F Bottini; M E Celle; M G Calevo; S Amato; G Minniti; L Montaldi; D Di Pasquale; R Cerone; E Veneselli; A C Molinari
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

4.  Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.

Authors:  Robert Y L Zee; Samia Mora; Suzanne Cheng; Henry A Erlich; Klaus Lindpaintner; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Clin Chem       Date:  2007-03-01       Impact factor: 8.327

5.  Elevated serum C-reactive protein levels and early arterial changes in healthy children.

Authors:  Mikko J Järvisalo; Aimo Harmoinen; Maarit Hakanen; Ulla Paakkunainen; Jorma Viikari; Jaakko Hartiala; Terho Lehtimäki; Olli Simell; Olli T Raitakari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

6.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

7.  Prediction of first events of coronary heart disease and stroke with consideration of adiposity.

Authors:  Peter W F Wilson; Samuel R Bozeman; Tanya M Burton; David C Hoaglin; Rami Ben-Joseph; Chris L Pashos
Journal:  Circulation       Date:  2008-07-08       Impact factor: 29.690

8.  Increased C-reactive protein in young adult patients with migraine.

Authors:  F H Vanmolkot; J N de Hoon
Journal:  Cephalalgia       Date:  2007-07       Impact factor: 6.292

9.  Physical and mental comorbidity of headache in a nationally representative sample of US adults.

Authors:  Amanda Kalaydjian; Kathleen Merikangas
Journal:  Psychosom Med       Date:  2008-08-25       Impact factor: 4.312

10.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

View more
  5 in total

1.  Evaluation of serum uric levels in migraine.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Ali Aygün; Volkan Karabacak; Yavuz Altunkaynak; Dursun Kirbaş
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

2.  Migraine and vascular disease biomarkers: A population-based case-control study.

Authors:  Gretchen E Tietjen; Jagdish Khubchandani; Nabeel Herial; Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Mark A van Buchem; Lenore J Launer; Michel D Ferrari; Mark C Kruit
Journal:  Cephalalgia       Date:  2017-03-15       Impact factor: 6.292

3.  Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates.

Authors:  Jihui Zhang; Femke Lamers; Ian B Hickie; Jian-Ping He; Emily Feig; Kathleen R Merikangas
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

Review 4.  Vitamin D in Children's Health.

Authors:  Joy A Weydert
Journal:  Children (Basel)       Date:  2014-09-12

5.  Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report.

Authors:  Joanna Sordyl; Ilona Kopyta; Beata Sarecka-Hujar; Tomasz Francuz; Paweł Matusik; Ewa Małecka-Tendera
Journal:  Arch Med Sci       Date:  2018-03-02       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.